Ulrika Maria Wennberg
Comptroller/Controller/Auditor en Huge Fastigheter AB .
Perfil
Ulrika Maria Wennberg is currently working as an Accountant at SRV Återvinning AB, Södertörns Energi AB, Södertörns Fjärrvärme AB, Huge Fastigheter AB, Söderenergi Kraftvärme AB, and Södertörns Utvecklingscentrum.
Previously, she worked as the Chief Executive Officer at Axelar AB, Chief Executive Officer & Chief Financial Officer at Jederstrom Pharmaceuticals AB, Director at DermaGen AB and Pergamum AB, and Chief Operating Officer at Promore Pharma AB and PharmaSurgics In Sweden AB.
Ms. Wennberg completed her undergraduate degree from the University of Lund.
Cargos activos de Ulrika Maria Wennberg
Empresas | Cargo | Inicio |
---|---|---|
Huge Fastigheter AB | Comptroller/Controller/Auditor | - |
Södertörns Utvecklingscentrum
Södertörns Utvecklingscentrum Miscellaneous Commercial ServicesCommercial Services Södertörns Utvecklingscentrum is a private company based in Huddinge, Sweden. The Swedish company provides professional services. | Comptroller/Controller/Auditor | - |
Söderenergi Kraftvärme AB | Comptroller/Controller/Auditor | - |
SRV Återvinning AB
SRV Återvinning AB SemiconductorsElectronic Technology SRV Återvinning AB is a private company based in Huddinge, SE. SRV Återvinning AB manufactures renewable energy semiconductor products. The Swedish company was founded in 1949. Mette Holst has been the CEO of the company since 2018. | Comptroller/Controller/Auditor | - |
Södertörns Fjärrvärme AB | Comptroller/Controller/Auditor | - |
Södertörns Energi AB | Comptroller/Controller/Auditor | - |
Antiguos cargos conocidos de Ulrika Maria Wennberg.
Empresas | Cargo | Fin |
---|---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Director de Operaciones | 01/01/2020 |
Axelar AB
Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Director Ejecutivo | 20/06/2018 |
Jederstrom Pharmaceuticals AB
Jederstrom Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Jederstrom Pharmaceuticals is a life sciences company that is developing new formulations for oral delivery of therapeutic proteins. These new formulations offer new and improved therapeutic possibilities, cost advantages and the convenience factor of oral administration. The vision of Jederstrom Pharmaceuticals is to make oral administration the method of choice for a number of key therapeutic proteins. Jederstrom Pharmaceuticals initial focus is to develop an insulin formulation for oral administration. Formulations of other well-known therapeutic proteins will then be developed. Jederstrom Pharmaceuticals' business model shall be out licensing. Jederstrom Pharmaceuticals was founded in 2001 by Gustaf Jederström, inventor of the formulation technology. Gustaf Jederström has more than 30 years experience of R&D in the pharmaceutical industry, where he has been instrumental in bringing numerous new pharmaceutical products to market. | Director Ejecutivo | 19/01/2012 |
░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Ulrika Maria Wennberg.
University of Lund | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 12 |
---|---|
Jederstrom Pharmaceuticals AB
Jederstrom Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Jederstrom Pharmaceuticals is a life sciences company that is developing new formulations for oral delivery of therapeutic proteins. These new formulations offer new and improved therapeutic possibilities, cost advantages and the convenience factor of oral administration. The vision of Jederstrom Pharmaceuticals is to make oral administration the method of choice for a number of key therapeutic proteins. Jederstrom Pharmaceuticals initial focus is to develop an insulin formulation for oral administration. Formulations of other well-known therapeutic proteins will then be developed. Jederstrom Pharmaceuticals' business model shall be out licensing. Jederstrom Pharmaceuticals was founded in 2001 by Gustaf Jederström, inventor of the formulation technology. Gustaf Jederström has more than 30 years experience of R&D in the pharmaceutical industry, where he has been instrumental in bringing numerous new pharmaceutical products to market. | Health Technology |
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
DermaGen AB
DermaGen AB Pharmaceuticals: MajorHealth Technology DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden. | Health Technology |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
Axelar AB
Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Huge Fastigheter AB | |
Södertörns Utvecklingscentrum
Södertörns Utvecklingscentrum Miscellaneous Commercial ServicesCommercial Services Södertörns Utvecklingscentrum is a private company based in Huddinge, Sweden. The Swedish company provides professional services. | Commercial Services |
Söderenergi Kraftvärme AB | |
SRV Återvinning AB
SRV Återvinning AB SemiconductorsElectronic Technology SRV Återvinning AB is a private company based in Huddinge, SE. SRV Återvinning AB manufactures renewable energy semiconductor products. The Swedish company was founded in 1949. Mette Holst has been the CEO of the company since 2018. | Electronic Technology |
Södertörns Fjärrvärme AB | |
Södertörns Energi AB |
- Bolsa de valores
- Insiders
- Ulrika Maria Wennberg